Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Blood Collection Tubes Stabilize DNA at Point of Collection

By Labmedica International staff writers
Posted on 11 Jun 2012
Print article
Tubes are available for the collection, preservation, and shipping of DNA in whole blood at ambient temperatures. Also available is a next generation liquid stabilizer that offers DNA preservation in both liquid and dry formats.

The Vacuette DNAgard Blood Tubes are for collection and the DNAstable Plus is the next generation liquid stabilizer that offers DNA preservation in both liquid and dry formats. RNAstable LD, which offers the ability to protect RNA using a liquid-to-dry format, enables automation compatibility

The three products expand Biomatrica's (San Diego, CA, USA) product portfolio for preserving biological samples at ambient temperatures. "We are keen to see the use of our technologies in the sample collection devices segment since their use in clinical and eventual diagnostic research has an immediate benefit to molecular diagnostics and the field of personalized medicine," said Dr. Rolf Muller, CSO at Biomatrica.

"We are excited to be working with the Biomatrica team and technology," said Manfred Buchberger, CEO Preanalytics of Greiner Bio-One (Kremsmünster, Austria). "The VACUETTE brand name has been successfully distributed to over 100 countries. The combination of Biomatrica technology with GBO's devices enables us to introduce innovative preanalytic solutions for the collection of human samples."

Biomatrica's product range maintains the integrity of DNA, RNA, saliva, blood, tissues, and cells both at the point of collection and point of detection. The SampleMatrix technology enables the use of ambient temperatures for sample collection, preservation, and detection resulting in maintenance of sample integrity, ease-of-use, and reduction of sample costs. The company's products have been adopted and validated at US government forensic agencies, academic research institutions, global biobanks, and diagnostic laboratories.

Related Links:

Biomatrica
Greiner Bio-One


Print article

Channels

Clinical Chemistry

view channel

New Approach Improves Identification of Women at High Risk of Preeclampsia

A new meta-analysis examining 92 cohort studies involving over 25 million pregnancies has provided an unprecedented understanding of risk factors for preeclampsia—some risk factors being strong enough to warrant that a pregnant woman starts on prophylactic treatment with acetylsalicylic acid (ASA) when she has only one.... Read more

Genetic Tests

view channel

Patterns of MicroRNA Expression Distinguish Patients with Asthma and Allergic Rhinitis

Subsets of circulating micro RNAs (miRNAs) are uniquely expressed in asthmatic patients and in patients with allergic rhinitis (AR) and have potential for use as noninvasive biomarkers to diagnose and characterize these diseases. MicroRNAs are a class of about 20 nucleotides-long RNA fragments that block gene expression... Read more

Pathology

view channel

Liver Cancer May Be Diagnosed from Altered Sugar Metabolism

Altered gene expression that causes cancerous cells to metabolize fructose differently from healthy cells could be a significant new biomarker for diagnosing liver cancer. Dietary fructose is primarily metabolized in the liver and it has now been demonstrated that, compared with normal hepatocytes, hepatocellular carcinoma... Read more

Industry News

view channel

R-Biopharm and Merck Partner on Companion Diagnostics

R-Biopharm AG (Darmstadt, Germany) and Merck KGaA (Darmstadt, Germany) have entered into an agreement that constitutes their first collaboration, which will initially focus on developing and launching companion diagnostics. Companion diagnostics play a central role in personalized medicine by helping to find specific... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.